Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO

RTTNews | 897天前
Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO

(RTTNews) - Ligand Pharmaceuticals Inc. (LGND) announced Monday that John Higgins has retired as Chief Executive Officer, effective as of today. Higgins will resign as a director of the company on December 31, 2022.

The company's board of directors has named Todd Davis as Chief Executive Officer. Davis is currently a member of Ligand's board of directors and is Managing Partner of RoyaltyRx Capital, a special opportunities investment firm he founded in 2018.

Davis has nearly 30 years of experience in biopharmaceutical and life sciences operations and investing.

Prior to founding RoyaltyRx Capital, Davis was a founder and Managing Partner at HealthCare Royalty Partners, a global healthcare investment firm. Previously, he was a partner responsible for biopharmaceutical growth equity investments at Apax Partners.

Davis began his career at Abbott Laboratories, where he held multiple sales and marketing positions of increasing responsibility. Subsequently, he led corporate development and held strategic planning and general management responsibilities at Elan Pharmaceuticals.

read more
Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults

Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults

Ligand Pharmaceuticals Inc. (LGND) announced Tuesday that its collaborator Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for CAPVAXIVE, previously known as V116, a 21-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in the adult population.
RTTNews | 336天前
DAX Up Over 0.5% In Cautious Trade

DAX Up Over 0.5% In Cautious Trade

German stocks are up in positive territory on Tuesday amid easing concerns about tariffs, and in reaction to the widely expected interest rate cut by the People's Bank of China.
RTTNews | 8分钟前
European Shares Inch Higher In Lackluster Trade

European Shares Inch Higher In Lackluster Trade

European shares inched higher on Tuesday as investors watched the latest developments on the trade front and reacted to widely expected rate cuts in China to stimulate consumption and loan growth.
RTTNews | 1小时9分钟前
Australian Dollar Falls After RBA Rate Cut Decision

Australian Dollar Falls After RBA Rate Cut Decision

The Australian dollar weakened against other major currencies in the Asian session on Tuesday, Australia's central bank lowered its benchmark rate by a quarter-point on Tuesday as risks to inflation became more balanced.
RTTNews | 1小时22分钟前
Australia Cuts Key Interest Rate For Second Time This Year

Australia Cuts Key Interest Rate For Second Time This Year

Australia's central bank lowered its benchmark rate by a quarter-point for the second time this year as risks to inflation became more balanced, while uncertainties regarding economic outlook increased due to trade protectionism measures. The policy board of the Reserve Bank of Australia, governed by Michele Bullock, decided to cut the cash rate target to 3.85 percent from 4.10 percent.
RTTNews | 2小时23分钟前
China Cuts Loan Prime Rates For First Time In 7 Months

China Cuts Loan Prime Rates For First Time In 7 Months

The People's Bank of China reduced its benchmark interest rate for the first time in seven months to stimulate consumption and support the property market amid soothing trade tensions. The central bank lowered its one-year loan prime rate by 10 basis points to 3.0 percent from 3.10 percent.
RTTNews | 3小时50分钟前